Medical device and MedTech insights, news, tips and more

Wearable Device Tricks Brain into Burning Fat

August 16, 2017

Burning Fat

The Modius Headset has been developed by Neurovalens, a neurotechnology company that claim its device can help end the obesity epidemic.

Burning FatThe company was founded by British doctors and neuroscientists Paul McGeoch and Jason McKeown, at the University of California San Diego. They claim that because the brain is linked to weight gain and loss, it can be stimulated to burn more fat.

Modius works by using electrical stimulation on the vestibular nerve, which controls sound and balance information from the ear to the brain. The brain then thinks that the stimulation is the body being more physically active, which activates the hypothalamus to reduce fat storage.

The developers claim that Modius can result in users burning more fat, a decrease in appetite and a change in metabolism. For those wondering if it works, Neurovalens looked at a range of studies that examined the effects stimulation on the vestibular nerve in animals. The authors of the study noted that after eight weeks, animals’ body fat was significantly lower and that there had been a metabolic shift to a leaner state.

Co-founder of Neurovalens, Paul McGeoch, said: “Weight gain and loss are controlled by your brain, which controls your appetite, your e, your metabolic rate, how much fat you store, and more. Our first device to market, Modius, is designed to resolve this issue by activating the epicentre of it all – your hypothalamus. Through advanced technological and neurological research, we’ve discovered the hypothalamus has a strong effect on people’s ability to lose and maintain weight.”

Read More at the Source: This wearable device can trick your brain into burning more fat – Medical Plastics News

by Reece Armstrong

 

More insights

November 11, 2024
What is the Difference Between MedTech and TechMed?  
Learn More
March 7, 2024
FDA Clears Dexcom’s First Over-the-Counter Continuous Glucose Monitor
Learn More
March 1, 2024
FDA greenlights Boston Scientific’s Novel Drug-Coated Balloon for Coronary In-Stent Restenosis
Learn More

Begin your legacy now. We are your medtech and medical device talent advisory firm.